Group A Streptococcus infections in children and adolescents in the post-COVID-19 era: a regional Italian survey
Bianca Laura Cinicola,Ilaria Sani,Federica Pulvirenti,Martina Capponi,Fabrizio Leone,Alberto Spalice,Agata Montalbano,Alessandra Macari,Maria Teresa Fonte,Paolo Gianni Giampietro,Danilo Buonsenso,Anna Maria Zicari,Teresa Rongai,Italian Pediatrician Federation (FIMP), Lazio Region,B Baldini Ferroli,R Brugnoli,F M Carpita,G Caruso,C Castellano,C Cives,L Costabile,R D'agostino,V De Vittori,A Fostira,C Grassi,I La Bella,A M Le Pera,A Masetti,D Morano,C Pontesilli,A Ragno,L Reali,P L Rotili,J Serafinelli,S Triarico,E Zirletta
DOI: https://doi.org/10.1186/s13052-024-01750-6
2024-09-16
Abstract:Background: Despite the worldwide increasing incidence of Group A Streptococcus (GAS) infections reported since December 2022, data on noninvasive GAS (nGAS) infections in the post COVID-19 era are limited. By a self-reported survey performed in an outpatient setting, we investigated the number and clinical features of GAS infections, the diagnostic work-up and the type of treatment utilized. In addition, the rate of influenza vaccination was evaluated. Methods: In June 2023 family pediatricians involved in the study sent the survey to parents of patients aged 0-16 years. The survey included questions on GAS infections that occurred from January 1 to May 31, 2023. Results: Among 3580 children, 20.3% had a GAS infection (0,8% < 1 year, 16,4% 1-3 years, 42,3% 3-6 years, 26,5% 6-9 years, 11,4%, 9-12 years, and 2,6% 12-16 years). Symptoms reported were sore throat (76.9%), fever (75.2%), tonsillar exudate (25.2%), lymphadenopathy (21.8%), and scarlet fever (14.7%). A single patient was hospitalized due to GAS meningitis. Twenty four percent of children had more than one GAS infection. In this group, frequencies of symptoms reported in the first and in the following infection were similar, except for fever and scarlet fever which were less frequent during relapses. GAS was identified by rapid antigen detection test in 81.0% of children. Eighty-nine per cent of children were treated with antibiotics, mostly amoxicillin/clavulanate (40.4%) and amoxicillin (39.4%). Thirty four percent of children received influenza vaccine. No difference was observed among immunized and not immunized regarding the number and characteristics of GAS infection. Conclusions: We reported a certain prevalence of nGAS infections in children, mainly those aged 3-6 years age, who were mostly characterized by a low score of symptoms, and in most of the cases diagnosed and treated using a microbiological test as confirmatory tool. In this new clinical setting, a national study would be useful to reach more significant data for the definition of a correct diagnosis and clinical management of nGAS infections in children. Moreover, it is important to improve flu vaccination campaign and coverage to protect children from coinfections that could worsen the disease and misdiagnose the etiology of pharyngitis.